Abstract
Rates of death and myocardial infarction were assessed for a national sample of acute coronary syndrome patients after stopping clopidogrel, in the first 90 days after stopping treatment, patients experienced a nearly twofold increased risk of adverse events compared with subsequent follow-up intervals for patients treated medically without stents and for patients treated with coronary stents. This suggests a possible clopidogrel rebound effect, but additional studies are needed to support this hypothesis and to identify strategies to reduce early events after clopidogrel cessation.
Original language | English (US) |
---|---|
Pages (from-to) | 13-18 |
Number of pages | 6 |
Journal | Cardiology Review |
Volume | 25 |
Issue number | 10 |
State | Published - Oct 2008 |
Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine